Jenaers bladder helps bladder cancer patients

Jenaer Harnblase
Jenaer Harnblase

(Jena). Urologists at the Jena University Hospital have developed a novel surgical procedure for the treatment of tumors of the urinary bladder. The unique „Jena bladder“ presented the Thuringian physicians currently at this year’s symposium on bladder cancer at the University Hospital Jena.

Jena urologists present novel surgical procedure for treating bladder tumors

Imagery Prof. Dr. Jörg Schubert: The new surgical method with partial preservation of the prostate

Imagery Prof. Dr. Jörg Schubert: The new surgical method with partial preservation of the prostate

The radical removal of the bladder (cystectomy) promises as the only method for healing deep into the bladder wall and aggressive tumors. The healing forecasts in this operation are very good.Nevertheless, the heavy 5-hour intervention for patients is very stressful because the bubble removal is also associated with significant changes in sexuality and therefore the partnerships of the affected men.

„The previously customary art bladders and bladder replacement solutions are connected to the bladder cancer patients with very significant limitations in quality of life – 94% of affected men were impotent after surgery, nearly half suffered from incontinence, and one in ten to problems such as narrowing of the artificial urinary tract, the follow-up operations made necessary „explains Professor Jörg Schubert. The partial preservation of the prostate also indispensable for male potency penis nerves are obtained with the new method. „At the same time we are able to secure the connection to the urethra and the urinary sphincter and so the possible incontinence prevent,“ says Schubert on.

By linking the bladder replacement with the prostate also is generated during the usual operation methods constrictions at the junction between Harnöhre art and bubble can be prevented. The „Jena bladder“ called construction of parts of the prostate and a bladder substitution was made possible by the combination of various vascular sparing surgical techniques that minimize the usually prostate surgery very high blood loss and shorten the surgical time. „We need for this intervention one hour earlier than before, and can completely renounce the use of blood transfusions,“ explains surgeon Prof. Schubert. With the new method, the very burdensome for the patient in the current standard form of surgery can now be offered to a wider circle of interested parties than before.

Bladder cancer, considered the second most common urological tumor after prostate cancer occurs mainly in men after age 60. Each year, approximately 15,000 people at a malignancy of the urinary bladder. At an advanced stage the radical removal of the bladder and use of bladder replacement is the only therapeutic option. The consequence for those involved is a life with the loss of control over urination, artificial urinary diversion and impotence.

Imagery Prof. Dr. Jörg Schubert: The new surgical method is gentle on the nerves carried out so that in male patients no erectile dysfunction occurs.

Imagery Prof. Dr. Jörg Schubert: The new surgical method is gentle on the nerves carried out so that in male patients no erectile dysfunction occurs.

This major setback in the quality of life want to prevent the future with the new process the Jena urologists. For half a year the method in the Department of Urology at the University Hospital is used. „The results are encouraging – the patients with“ bladder Jena „have no erectile dysfunction and no problems with incontinence,“ says Prof. Schubert.

For more information:
Prof. Dr. Jörg Schubert
Director of the Department of Urology, University Hospital Jena
Tel. 03641-935206
Email: joerg.schubert@med.uni-jena.de

Press release of the University Hospital Jena

Treatment of infiltrated bladder tumors


Krebszeitung

--Download Jenaers bladder helps bladder cancer patients als PDF-Datei --


  • Pressekonferenz über die Priorisierung und Forschungsförderung
    DGU-Kongress 2013

    „Wissenschaftlicher Fortschritt entscheidet über unsere Zukunft“

    Dresden/ Homburg, 05.02.2013. Der Präsident der Deutschen Gesellschaft für Urologie e.V. ist überzeugt: „Wenn ein wissenschaftliches Fachgebiet aufhört, die kontinuierliche Erzeugung von wissenschaftlichem Fortschritt als seine wesentliche Daseinsberechtigung zu definieren, wird es auf die Dauer seine Existenzgrundlage verlieren.“

    Die Wissenschaftsstruktur in der Urologie zu fördern, ist für Prof. Dr. Michael Stöckle deshalb eine Herzensangelegenheit. In den zehn Jahren seiner Vorstandstätigkeit gelang es der Fachgesellschaft in einer großen gemeinsamen Kraftanstrengung, vorhandenem Wissenschaftsdefizit in der Urologie mit der Gründung des Forschungsressorts, der Arbeitgemeinschaft Urologische Forschung (AUF), des Urologischen Studienregisters und der Etablierung der Eisenberger-Stipendien zu begegnen.

    „Beim Aufbau einer nachhaltigen Forschungslandschaft an deutschen Urologischen Universitätskliniken haben wir erhebliche strukturelle Verbesserungen erreicht, die der Öffentlichkeit und insbesondere natürlich dem wissenschaftlichen Nachwuchs sichtbar machen, dass wissenschaftlicher Fortschritt auf der Agenda der DGU ganz weit oben steht“ sagt der Direktor der Klinik für Urologie und Kinderurologie am Universitätsklinikum des Saarlandes.

    […mehr lesen]

  • Kein Bild
    Hirntumoren
    Bedeutung der PET-MRT für die individualisierte Therapie – Intensive Diskussion auf der Jahrestagung der Deutschen Gesellschaft für Neuroradiologie e.V. Köln, 23. Oktober 2014. Nach Angaben des Robert Koch-Instituts versterben pro Jahr in Deutschland über 5.500 [...mehr lesen]

Google News – Gesundheit